Discovering what causes 4E-BP2 deamidation will make it possible to control this balance of protein production and develop effective treatments against neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This evidence concerns the gene EIF4EBP2 and Parkinson disease.